LATEST PSYCHEDELICS STOCKS NEWS

Better Plant Sciences Announces Website Launch and Strategic Plan to Grow Direct-to-Consumer Sales

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: BOSQF) (FSE: YG3) ("Better") or (the "Company") is pleased to provide an update on the Company's strategic plan to grow its direct-to-consumer ecommerce sales. This includes the re-launch of the company website, pending acquis... Read More...

Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19TORONTO, Aug. 26, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased ... Read More...

Codebase Investment, World High Life, Announces Georges St-Pierre Special on BT SPORT in the UK

VANCOUVER, BC / ACCESSWIRE / August 26, 2020 / Codebase Ventures Inc. ("Codebase") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces that World High Life Plc, (AQSE: LIFE) (OTCQB: WRHLF), in which the Company has invested, has announced that brand ambassador Georges St-Pierre will be showcased on BT Sport, one of Europe's largest sport networks ... Read More...

Yukoterre Resources Enters Into Amalgamation Agreement With Psychedelics Company Silo Wellness

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 25, 2020 -- YUKOTERRE RESOURCES INC. (“Yukoterre”) (CSE:YT), is pleased to announce that further to the press release dated June 17, 2020, it has entered into an amalgamation agreement dated August 25, 2020 with FlyOverture Equit... Read More...

Better Plant Sciences Submits Application for Ayurvedic Skin Ointment to Combat Infectious Disease

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: BOSQF) (FSE:YG3) ("Better") subsidiary Urban Juve Provisions Inc. ("Urban Juve") announces that it has conducted research and development into plant-based topical products that fight against or prevent infectious diseases leadi... Read More...

BMO Financial Group Declares Dividends

TORONTO, Aug. 25, 2020 - Bank of Montreal (TSX: BMO) (NYSE: BMO) today announced that its Board of Directors declared a quarterly dividend of $1.06 per share on paid-up common shares of Bank of Montreal for the fourth quarter of fiscal year 2020 ("Q4 2020 Dividend"), unchanged from the previous quarter and up 3 per cent from the prior yea... Read More...

Empower Clinics Reports Q2 2020 Results with 56% Revenue Increase and YTD 2020 with 130% Revenue Increase

VANCOUVER, BC / ACCESSWIRE / August 25, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF) (Frankfurt:8EC) ("Empower" or the "Company") has filed today its unaudited condensed interim financial statements and related management's discussion and analysis, both of which are available at www.SEDAR.com. All financial information in this pres... Read More...

Organic Flower Looks to Augment Investment Portfolio With Hydrogen Sector Investment

VANCOUVER, British Columbia, Aug. 21, 2020 -- Organic Flower Investments Group Inc. (CSE: SOW)(FWB: 2K6)(OTC: QILFF) (“Organic Flower” or the “Company”) is pleased to announce that it has entered into a letter of intent (the “Letter of Intent”), dated August 12, 2020, to acquire up to a 13% equity interest in a U.S.-based company, which o... Read More...

Revive Therapeutics to Expand Phase 3 Clinical Trial for Bucillamine in COVID-19 in Asia-Pacific and Canada

TORONTO, Aug. 19, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that following the U.S. Food & Drug Administration (“U.S. FDA”) approval to procee... Read More...

Graph Blockchain Announces Shares for Debt Settlement

Toronto, Ontario--(Newsfile Corp. - August 19, 2020) - Graph Blockchain Inc. (CSE: GBLC) (the "Company" or "Graph") announces that it has entered into debt settlement agreements (the "Settlement Agreements") with three creditors (the "Creditors") to settle an aggregate of $336,004 in debt (the "Debt") for services provided by the Creditor... Read More...

Osoyoos Provides Board Update; Approves Name Change

Toronto, Ontario--(Newsfile Corp. - August 19, 2020) - Osoyoos Cannabis Inc. (CSE: OSO) ("Osoyoos" or the "Company") is pleased to provide a Board of Directors ("Board of Directors" or the "Board") update following the recent election of the Company's new Board of Directors which includes the appointment of a new Executive Chair, Executiv... Read More...

Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

Being Facilitated Under a Schedule 1 Health Canada Dealer’s LicenseDENVER, Aug. 18, 2020 -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine™") is pleased to announce it is the first organization to exercise its cGMP(₁) capabilities under a special license to legally produce, transfer, sell, and export pharma... Read More...

Thoughtful Brands Enters into Letters of Intent to Consider Acquisitions of Golden Path and Wild Mariposa

VANCOUVER, BC / ACCESSWIRE / August 17, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1:GR)(OTCQB:PEMTF) (the "Company") is pleased to announce that it has entered into letters of intent (collectively, the "Letters of Intent"), each dated August 17, 2020, with Golden Path LLC ("Golden Path") and Wild Mariposa LLC ("Wild Mariposa"), pursu... Read More...

Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 14, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, US: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has signed a Memorandum of Understanding (“MOU”) with Attwill Medical Solutions... Read More...

Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

DENVER, Aug. 13, 2020 -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine"), is pleased to announce that NeuroPharm Inc., a company focused on developing unique mental health therapies and approaches for veteran wellness, was recently covered in Forbes for its ground-breaking psilocybin clinical trials for trea... Read More...

Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

DENVER, Aug. 12, 2020 -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" “MIG”), is pleased to provide a corporate update regarding recent advancements and achievements that continues to add shareholder value and position Mydecine as a genuine leader in the ever-expanding fungi and psychedelic sectors. Throug... Read More...

PharmaDrug Inc. Enters into Definitive Agreement to Acquire First Smart Shop in the Netherlands

Toronto, Ontario--(Newsfile Corp. - August 11, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") is pleased to announce that its wholly-owned subsidiary Interrobang Ltd. (doing business as Super Smart) ("Super Smart") has entered into a definitive agreement to acquire (the "Acquisition") a retail establ... Read More...

Empower Covid-19 Testing Growth Adds to Revenue Diversification with Record July 2020 Patient Visits and Record Revenue Per Patient

Empower July 2020 patient volume surpasses 2,300 patients with Sun Valley Health increasing revenue per patient by 29%, and adds 426 COVID-19 patient tests in July 2020 pilot testing programVANCOUVER, BC / ACCESSWIRE / AUGUST 11, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC) ("Empower" or the "Company"), a life scie... Read More...

Codebase Ventures Inc. Announces Closing of Financing

VANCOUVER, BC / ACCESSWIRE / August 7, 2020 / Codebase Ventures Inc. ("Codebase") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed the final tranche of its non-brokered private placement (the "Financing"). In the first tranche the Company raised proceeds of $135,000 through the sale of 2,250,000 Units. The final tranche the Com... Read More...

Graph Blockchain Enters into a Binding Letter of Intent to Acquire Third Eye Insights Corp

Toronto, Ontario--(Newsfile Corp. - August 6, 2020) - Graph Blockchain Inc. (CSE: GBLC) ("Graph" or the "Company") announces it has entered into a binding letter of intent ("LOI") in connection with the proposed acquisition of Third Eye Insights Corp. ("Third Eye" or "Seller"), to acquire 100% of all issued and outstanding shares of Third... Read More...

MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy

Applauds Health Canada's Approval Of Psilocybin Compassionate Access For PatientsNEW YORK, Aug. 6, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has engaged renowned psychedelic assisted therapy expert Dr. Peter Gasser as an advisor to its LSD experiential therapy program Pr... Read More...